Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 769

Similar articles for PubMed (Select 10520944)

1.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
2.

Extrapyramidal signs in patients with probable Alzheimer disease.

Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1997 Aug;54(8):969-75.

PMID:
9267971
3.

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.

Lopez OL, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST.

Neurology. 1997 Jun;48(6):1521-5.

PMID:
9191759
5.

Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.

Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST.

J Am Geriatr Soc. 2005 Jan;53(1):83-7.

PMID:
15667381
6.

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.

Lopez OL, Becker JT, Chang YF, Sweet RA, Aizenstein H, Snitz B, Saxton J, McDade E, Kamboh MI, DeKosky ST, Reynolds CF 3rd, Klunk WE.

Am J Psychiatry. 2013 Sep;170(9):1051-8. doi: 10.1176/appi.ajp.2013.12081046.

7.

Longitudinal outcome of Parkinson's disease patients with psychosis.

Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R; Parkinson Study Group.

Neurology. 2003 Jun 10;60(11):1756-61.

PMID:
12796526
9.

Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.

Chui HC, Lyness SA, Sobel E, Schneider LS.

Arch Neurol. 1994 Jul;51(7):676-81.

PMID:
8018040
10.

Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.

Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M.

J Clin Psychiatry. 2001 Nov;62(11):894-900.

PMID:
11775050
11.

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R.

Arch Gen Psychiatry. 1996 Feb;53(2):175-82.

PMID:
8629893
12.

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.

Kurlan R, Cummings J, Raman R, Thal L; Alzheimer's Disease Cooperative Study Group.

Neurology. 2007 Apr 24;68(17):1356-63.

PMID:
17452579
13.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
14.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
15.
16.

Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.

Harwood DG, Sultzer DL, Wheatley MV.

Neuropsychiatry Neuropsychol Behav Neurol. 2000 Apr;13(2):83-8.

PMID:
10780626
17.

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME.

J Am Geriatr Soc. 2001 Oct;49(10):1294-300.

PMID:
11890487
18.

A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.

Weiner MF, Koss E, Patterson M, Jin S, Teri L, Thomas R, Thal LJ, Whitehouse P.

J Psychiatr Res. 1998 Nov-Dec;32(6):347-51.

PMID:
9844950
19.
20.

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.

Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST.

J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):310-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk